Skip to main content
Log in

Inhibition of human parainfluenza virus type 1 sialidase by analogs of 2-deoxy-2,3-didehydro-N-acetylneuraminic acid

  • Published:
Glycoconjugate Journal Aims and scope Submit manuscript

Abstract

Eleven novel analogs of 2-deoxy-2,3-didehydro-N-acetylneuraminic acid (Neu5Ac2en) modified at the C-4 and C-9 positions were designed and tested for their ability to inhibit sialidase of human parainfluenza virus type 1 (hPIV-1). The analogs modified by the cyanomethyl, amidinomethyl, and thiocarbamoylmethyl groups at the C-4 position exhibited potent inhibition against hPIV-1 sialidase compared with Neu5Ac2en. The most effective compound was thiocarbamoylmethyl analog (4-O-thiocarbamoylmethyl-Neu5Ac2en). The activity of 4-O-thiocarbamoylmethyl-Neu5Ac2en causing 50% enzyme inhibition at a concentration of approximately 1.0×10−5M was 30-fold larger than Neu5Ac2en. While, the analogs of Neu5Ac2en modified by the azido and N-acetyl groups at the C-9 showed a decrease in inhibition of sialidase compared with the 9-hydroxy analogs. In addition, 4-O-thiocarbamoylmethyl-Neu5Ac2en strongly inhibited hPIV-1 infections of Lewis lung carcinoma-monkey kidney cells in comparison with Neu5Ac2en. The present findings would provide useful information for the development of anti-human parainfluenza virus compounds.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Collins PL, Chanock RM, McIntosh K, Parainfluenza viruses. In Fields Virology, Fields BN, Knipe DM, Howley PM, (eds), Lippincott-Raven, Philadelphia, 1996, pp. 1205–41.

    Google Scholar 

  2. Murphy BR, Parainfluenza viruses. In Infectious Diseases, Gorbach SL, Bartlett JG, Blacklow NR, (eds), W. B. Saunders Company, Philadelphia, 1998, pp. 2125–31.

    Google Scholar 

  3. Chanock RM, Parrott RH, Cook KM, Andrews BE, Bell JE, Reichelerfer T, Pakpkian AK, Mastrota FM, Huebner RJ, Newly recognized myxoviruses from children with respiratory disease, N Engl J Med 258, 207–13 (1958).

    Google Scholar 

  4. Kessler N, Bardeletti G, Aymard M, The neuraminidase of human parainfluenza 1 virus (HA2 virus), J Gen Virol 37, 547–56 (1977).

    Google Scholar 

  5. Markwell MA, New frontiers opened by the exploration of host cell receptors. In Paramyxoviruses, Kingsbury DW, (ed), Plenum Press, New York, 1991, pp. 407–25.

    Google Scholar 

  6. Suzuki T, Harada M, Suzuki Y, Matsumoto M, Incorporation of sialoglycoprotein containing lacto-series oligosaccharides into chicken asialoerythrocyte membranes and restoration of receptor activity toward hemagglutinating virus of Japan (Sendai virus), J Biochem 95, 1193–200 (1984).

    Google Scholar 

  7. Suzuki Y, Suzuki T, Matsunaga M, Matsumoto M, Gangliosides as paramyxovirus receptor. Structural requirement of sialo-oligosaccharides in receptors for hemagglutinating virus of Japan (Sendai virus) and Newcastle disease virus, J Biochem 97, 1189–99 (1985).

    Google Scholar 

  8. Huberman K, Peluso RW, Moscona A, Hemagglutinin-neuraminidase of human parainfluenza 3: Role of the neuraminidase in the viral life cycle, Virology 214, 294–300 (1995).

    Google Scholar 

  9. Meindl P, Bodo G, Palese P, Schulman J, Tuppy H, Inhibition of neuraminidase activity by derivatives of 2-deoxy-2,3-dehydro-Nacetylneuraminic acid, Virology 58, 457–63 (1974).

    Google Scholar 

  10. Perlman SL, Jordan M, Brossmer R, Greengard O, Moscona A, The use of a quantitative fusion assay to evaluate HN-receptor interaction for human parainfluenza virus type 3, Virology 265, 57–65 (1999).

    Google Scholar 

  11. Itzstein MV, Wu W-Y, Kok GB, Pegg MS, Dyason JC, Jin B, Phan TV, Smythe ML, White HF, Oliver SW, Colman PM, Varghese JN, Ryan DM, Cameron JM, Penn CR, Rational design of potent sialidase-based inhibitors of influenza virus replication, Nature 363, 418–23 (1993).

    Google Scholar 

  12. Greengard O, Poltoratskaia N, Leikina E, Zimmerberg J, Moscona, A, The anti-influenza virus agent 4-GU-DANA (Zanamivir) inhibits cell fusion mediated by human parainfluenza virus and influenza virus HA, J Virol 74, 11108–14 (2000).

    Google Scholar 

  13. Crennell S, Takimoto T, Portner A, Taylor G, Crystal structure of the multifunctional paramyxovirus hemagglutinin-neuraminidase, Nat Struct Biol 7, 1068–74 (2000).

    Google Scholar 

  14. Ikeda K, Sano K, Ito M, Saito M, Hidari K, Suzuki T, Suzuki Y, Tanaka K, Synthesis of 2-deoxy-2,3-didehydro-N-acetylneuraminic acid analogs modified at the C-4 and C-9 positions and their behaviour towards sialidase from influenza virus and pig liver membrane, Carbohydr Res 330, 31–41 (2001).

    Google Scholar 

  15. Henrickson KJ, Savatski LL, Genetic variation and evolution of human parainfluenza virus type 1 hemagglutinin neuraminidase: Analysis of 12 clinical isolates, J Infect Dis 166, 995–1005 (1992).

    Google Scholar 

  16. Gorman WL, Pridgen C, Portner A, Glycosylation of the hemagglutinin-neuraminidase glycoprotein of human parainfluenza virus type 1 affects its functional but not its antigenic properties, Virology 183, 83–90 (1991).

    Google Scholar 

  17. Portner A, Scroggs RA, Metzger DW, Distinct functions of antigenic sites of the HN glycoprotein of Sendai virus, Virology 158, 61–8 (1987).

    Google Scholar 

  18. Suzuki T, Sometani A, Yamazaki Y, Horiike G, Mizutani Y, Masuda H, Yamada M, Tahara H, Xu G, Miyamoto D, Oku N, Okada S, Kiso M, Hasegawa A, Ito T, Kawaoka Y, Suzuki Y, Sulphatide binds to human and animal influenza A viruses, and inhibits the viral infection, Biochem J 318, 389–93 (1996).

    Google Scholar 

  19. Conyers SM, Kidwell DA, Chromogenic substrates for horseradish peroxidase, Anal. Biochem 192, 207–11 (1991).

    Google Scholar 

  20. Holzer CT, Itzstein MV, Jin B, Pegg MS, Stewart WP, Wu W-Y, Inhibition of sialidase from viral, bacterial and mammalian sources by analogs of 2-deoxy-2,3-didehydro-N-acetylneuraminic acid modified at C-4 position, Glycoconjugate J 10, 40–4 (1993).

    Google Scholar 

  21. Shibuta H, Nozawa A, Shioda T, Kanda T, Neuraminidase activity and syncytial formation in variants of parainfluenza 3 virus, Infect Immun 41, 780–8 (1983).

    Google Scholar 

  22. Schreiner E, Zbiral E, Kleineidam RG, Schauer R, 2,3-Didehydro-2-deoxysialic acids structurally varied at C-5 and their behaviour towards the sialidase from Vibrio cholerae, Carbohydr Res 216, 61–6 (1991).

    Google Scholar 

  23. Zbiral E, Kleineidam RG, Schreiner E, Hartmann M, Christian R, Schauer R, Elucidation of the topological parameters of N-acetylneuraminic acid and some analogs involved in their interaction with the N-acetylneuraminate lyase from Clostridium perfringens, Biochem J 282, 511–6 (1992).

    Google Scholar 

  24. Suzuki T, Portner A, Scroggs RA, Uchikawa M, Koyama N, Matsuo K, Suzuki Y, Takimoto, T, Receptor specificities of human respiroviruses, J Virol 75, 4604–13 (2001).

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Suzuki, T., Ikeda, K., Koyama, N. et al. Inhibition of human parainfluenza virus type 1 sialidase by analogs of 2-deoxy-2,3-didehydro-N-acetylneuraminic acid. Glycoconj J 18, 331–337 (2001). https://doi.org/10.1023/A:1013617232576

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1013617232576

Navigation